Early Effect of Single-dose Sitagliptin Administration on Gastric Emptying: Crossover Study Using the 13C Breath Test

Takashi NONAKA; Yusuke SEKINO; Hiroshi IIDA; Eiji YAMADA; Hidenori OHKUBO; Eiji SAKAI; Takuma HIGURASHI; Kunihiro HOSONO; Hiroki ENDO; Tomoko KOIDE; Hirokazu TAKAHASHI; Koji FUJITA; Masato YONEDA; Ayumu GOTO; Akihiko KUSAKABE; Noritoshi KOBAYASHI; Eiji GOTOH; Shin MAEDA; Atsushi NAKAJIMA; Chihiro NOSAKA; Masahiko INAMORI.
Journal of Neurogastroenterology and Motility ; : 227-232, 2013.
Artículo en Inglés | WPRIM | ID: wpr-86417

Documentos relacionados

  1. Analytical quality by design approach for the development of high-performance liquid chromatography method for simultaneous analysis of metformin and sitagliptin in the presence of major degradation products.
  2. Incretin-Based Therapies for the Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes.
  3. Stimulatory effect of imeglimin on incretin secretion.
  4. Comparative effects of weight loss and incretin-based therapies on vascular endothelial function, fibrinolysis and inflammation in individuals with obesity and prediabetes: A randomized controlled trial.
  5. Practical Asymmetric Synthesis of Sitagliptin Phosphate Monohydrate.
  6. Pharmacokinetics of Metformin in Combination With Sitagliptin in Adult Horses After Enteral Administration.
  7. Sitagliptin and fucoidan prevent apoptosis and reducing ER stress in diabetic rat testes.
  8. [Quantification of sitagliptin in human plasma and urine by LC-MS/MS method and its application].
  9. [Incretin strategy in the treatment of type 2 diabetes mellitus--the DPP-IV inhibitor sitagliptin].
  10. Development and validation of rapid ultra high performance liquid chromatography with tandem mass spectroscopic method for the quantification of N-nitrosodimethyl amine and N-nitrosodiethyl amine in sitagliptin and metformin hydrochloride immediate and extended-release formulations.